Literature

Search Literature

You can search and request for digital copy(ies) of literature listed below. Your request will be processed within 5-10 business days. (You need to log in to request literature copies.) To read the abstracts, click on the DOI Link button.

Keyword

Filter by Protein Type

Filter by Contents

Filter by Products

You need to log in to request literature copies.

Select the literature you wish to request a copy of. To read the abstracts, click on teh DOI Link button.

41 Results Found

  1. 10
  2. 20
  3. 30
  4. All

  1. Pathogen safety of intravenous Rh immunoglobulin liquid and other immune globulin products: Enhanced nanofiltration and manufacturing process overview

    DOI Link
    Author
    Soluk, L., et al
    		 Organization
    Cangene Corporation and Baxter Healthcare Corporation
    Journal
    American Journal of Therapeutics 15: 435-443
    		 Year
    2008
    Access
    Abstract Only

  2. Capacity of the manufacturing process of Flebogamma® DIF, a new human high purity intravenous immunoglobulin, to remove a TSE model-agent

    DOI Link
    Author
    Diez, J. M., et al.
    		 Organization
    Instituto Grifols S. A.
    Journal
    Biologicals 38: 670-674
    		 Year
    2010
    Access
    Abstract Only

  3. Virus removal from Factor IX by filtration: Validation of the integritytest and effect of manufacturing process conditions

    DOI Link
    Author
    Roberts, P. L., et al.
    		 Organization
    Bio Products Laboratory
    Journal
    Biologicals 38: 303-31010
    		 Year
    2010
    Access
    Abstract Only

  4. Viral safety of C1-inhibitor NF

    DOI Link
    Author
    Terpstra, F. G., et al.
    		 Organization
    Sanquin Research and Landsteiner Laboratory of the Academic Medical Center of the University of Amsterdam and Sanquin Plasma Products
    Journal
    Biologicals 35: 173-181
    		 Year
    2007
    Access
    Abstract Only

  5. Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" albumin solutions

    DOI Link
    Author
    Cardone, F., et al.
    		 Organization
    Istituto Superiore di Sanità, CEA/DSV/iMETI/SEPIA and LFB
    Journal
    Transfusion 52: 953–962
    		 Year
    2012
    Access
    Abstract Only

  6. Removal of small non-enveloped viruses by nanofiltration

    DOI Link
    Author
    Yokoyama, T., et al.
    		 Organization
    Japanese Red Cross and Sapporo Medical University School of Medicine & Department of Microbiology
    Journal
    Vox Sanguinis 86: 225–229
    		 Year
    2004
    Access
    Abstract Only

  7. Nanofiltration, a new specific virus elimination method applied to high-purity Factor IX and Factor XI concentrates

    DOI Link
    Author
    Burnouf-Radosevich, M., et al.
    		 Organization
    Centre Régional de Transfusion Sanguine
    Journal
    Vox Sanguinis 67: 132-138
    		 Year
    1994
    Access
    Abstract Only

  8. Prion removal by nanofiltration under different experimental conditions

    DOI Link
    Author
    Yunoki, M., et al.
    		 Organization
    Osaka University, Benesis Corporation, Mitsubishi Pharma Corporation, and Invitrogen BioServices
    Journal
    Biologicals 36: 27-36
    		 Year
    2008
    Access
    Abstract Only

  9. Manufacturing process of Anti-thrombin III concentrate: viral safety validation studies and effect of column re-use on viral clearance

    DOI Link
    Author
    Morrica, A., et al.
    		 Organization
    Kedrion S.p.A. and Q-ONE Biotech Ltd
    Journal
    Biologicals 31: 165-173
    		 Year
    2003
    Access
    Abstract Only

  10. Phage passage after extended processing in small-virus-retentive filters

    DOI Link
    Author
    Lute, S., et al.
    		 Organization
    Food and Drug Administration and Eli Lilly and Company
    Journal
    Biotechnol. Appl. Biochem. 47: 141-151
    		 Year
    2007
    Access
    Abstract Only
Previous Next Page